Goal: To develop a computationally efficient and unbiased synthetic data generator for large-scale in silico clinical trials (CTs). Methods: We propose the BGMM-OCE, an extension of the conventional BGMM (Bayesian Gaussian Mixture Models) algorithm to provide unbiased estimations regarding the optimal number of Gaussian components and yield high-quality, large-scale synthetic data at reduced computational complexity. Spectral clustering with efficient eigenvalue decomposition is applied to estimate the hyperparameters of the generator. A case study is conducted to compare the performance of BGMM-OCE against four straightforward synthetic data generators for in silico CTs in hypertrophic cardiomyopathy (HCM). Conclusions: BGMM-OCE overcomes the lack of population size in HCM which obscures the development of targeted therapies and robust risk stratification models.
Bayesian Inference-Based Gaussian Mixture Models with Optimal Components Estimation Towards Large-Scale Synthetic Data Generation for in Silico Clinical Trials / Pezoulas V.C., Tachos N.S., Gkois G., Olivotto I., Barlocco F., Fotiadis D.I.. - In: IEEE OPEN JOURNAL OF ENGINEERING IN MEDICINE AND BIOLOGY. - ISSN 2644-1276. - ELETTRONICO. - 3:(2022), pp. 108-114. [10.1109/OJEMB.2022.3181796]
Bayesian Inference-Based Gaussian Mixture Models with Optimal Components Estimation Towards Large-Scale Synthetic Data Generation for in Silico Clinical Trials
Olivotto I.;Barlocco F.;
2022
Abstract
Goal: To develop a computationally efficient and unbiased synthetic data generator for large-scale in silico clinical trials (CTs). Methods: We propose the BGMM-OCE, an extension of the conventional BGMM (Bayesian Gaussian Mixture Models) algorithm to provide unbiased estimations regarding the optimal number of Gaussian components and yield high-quality, large-scale synthetic data at reduced computational complexity. Spectral clustering with efficient eigenvalue decomposition is applied to estimate the hyperparameters of the generator. A case study is conducted to compare the performance of BGMM-OCE against four straightforward synthetic data generators for in silico CTs in hypertrophic cardiomyopathy (HCM). Conclusions: BGMM-OCE overcomes the lack of population size in HCM which obscures the development of targeted therapies and robust risk stratification models.I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.



